OOIR: Observatory of International Research

Papers

(The TQCC of Nephrology Dialysis Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases	311
Anti-C1Q monitoring predicts relapses of lupus nephritis	207
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections	141
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION	131
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy	107
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease	100
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES	91
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe	89
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS	80
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease	79
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	71
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS	70
#2294 Muscle ultrasound as a tool for morphofunctional assessment in patients with chronic kidney disease	69
#4585 POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: COMPARISON OF RISK AND PROGNOSTIC FACTORS BETWEEN KIDNEY AND OTHER ORGAN TRANSPLANT RECIPIENTS	64
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?	64
#1818 Association of combined systemic inflammatory indices with the severity and outcome of tunnelled hemodialysis catheter-related bacteremia	62
#2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications	62
#5285 SERUM IRON AND NUTRITIONAL STATUS ARE ASSOCIATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE	61
#2118 Monitoring hemodynamics in dialysis: on the feasibility of semi-continuous and multifrequency thoracic bioimpedance measurements by a wearable device	61
#1350 Finerenone in real-life clinical practice: first results from a pilot study	60
#3140 THE WEST OF SCOTLAND AND THROMBOTIC MICROANGIOPATHY	60
#2695 A Polycystin-1-Bicaudal C1 complex regulates focal adhesion function through integrin beta-1, F-actin organisation and local translation in HKE cells	58
#1834 Prevalence of nephrolithiasis in patients with idiopathic hypercalciuria after two decades of follow-up	56
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY	56
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER	55

#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS	55
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE	54
#5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE	54
#4720 SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN	54
#5349 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY	53
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD	53
#3166 RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS	52
#761 Effect of ketoanalogue-supplemented very low protein diet in the need to initiate renal replacement in chronic kidney disease patients	52
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES	51
#3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN	50
#651 Diagnostiс criteria of the functional state of the kidneys in patients with type 2 diabetes mellitus	50
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS	49
#1962 Development of triple-whammy induced pre-renal AKI is highly dependent on the hydration status	48
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS	47
#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHRONIC KIDNEY DISEASE (CKD)	46
#1315 Management and long-term outcome of recurrent idiopathic FSGS in pediatric renal transplant recipients	46
#2251 Long-term systolic blood pressure variability as an independent risk factor for cardiovascular events in kidney transplant recipients	45
#3121 THE EFFECTIVENESS OF A GLUTEN-FREE DIET IN PATIENTS WITH IGA NEPHROPATHY	44
#1795 Diverse histological findings of kidney injury in cancer patients on immunotherapy- impact on clinical management	43
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE	43
#1076 DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/ P66shc signaling pathway in diabetic kidney disease	43
#1846 Oxalate nephropathy in diabetic kidney disease: another factor to take into account?	43
#635 Effect of multi-biomarker panels based on urinary N-terminal osteopontin on prediction of diabetic kidney disease in patients with diabetes mellitus	42
#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD	42
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS	42
#1716 IgA nephropathy: our center's experience	42
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION	41
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS	40
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES	40
#1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project	40
#2529 The role of the circadian clock system in the transition from acute kidney injury to chronic kidney disease	40
#821 Kibra mediates the activation of hippo by classic signal pathway related to NPHP1 defect	39
#2556 Therapeutic monitoring in patients with APRT deficiency using UPLC-MS/MS-based plasma assay	39
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?	39
#972 A Novel Single Compound from Chinese Herbs as a Potential Candidate for Reducing obesity induced diabetic nephropathy via ATF3-RARRES1 axis pathway	39
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?	39
#4554 FRAX® ASSOCIATION, BONE DENSITOMETRY, BIOCHEMICAL PARAMETERS OF BONE MINERAL METABOLISM AND ADVANCED CHRONIC KIDNEY DISEASE	38
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	38
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY	38
#2740 Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease	37
#860 The role of immunocorrection in the treatment of patients chronic pyelonephritis	37
#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY	37
#2699 Rare glomerular microangiopathy: clinicopathological characteristics and prognosis	37
#2963 Light chain deposition in the kidney is more frequent in patients with proliferative lupus nephritis	37
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS	37
#814 Inflammatory biomarkers and progression of diabetic kidney disease	36
#543 Cognitive improvement in end stage renal disease patients post transplantation—a prospective observational study	36
#2116 Socioeconomic position and incidence of chronic kidney disease in Central Italy	35
#1839 Evaluating the severity of restless legs syndrome in chronic kidney disease patients across different renal replacement therapies	35
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS	34

#5142 THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT	34
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS	34
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL	34
#2439 The association between vitamin D deficiency and sarcopenia in patients with pre-dialysis CKD	34
#1704 GLP-1RA versus DPP-4 inhibitors and rates of hyperkalemia and discontinuation of renin-angiotensin system (RAS) blockade in Swedish routine care	34
#2685 SLC34A2 EXACERBATES TUBULAR INTERSTITIAL FIBROSIS VIA INDUCTION OF APOPTOSIS AND CELL CYCLE ARREST IN S PHASE	33
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG	33
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE	33
#1304 Clinical characteristics of acute kidney injury caused by Phytolaccaceae ingestion	33
#2450 Alternative splicing in podocytes under mechanical stress: a new perspective for the pathogenic effect of glomerular hypertension	32
#1297 Approaches to renal response assessment in rare monoclonal immunoglobulin related glomerulopathies	32
#2394 Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence	32
#2388 Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome in patients with membranous nephropathy	32
#5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE	32
#1906 Lung ultrasound as a valid tool for fluid assessment in dialysis patients: a systematic review	31
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE	31
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA	30
#1916 Infective endocarditis in young female hemodialysis patient: a case report and literature review	30
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS	30
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE	30
#289 Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease by upregulating STAT3/NCOA4-mediated ferritinophagy and ferroptosis	30
#1914 Comprehensive single-cell sequencing and lipidomics identify diverse injury states and cholesterol dynamics of the PTs in AKI-to-CKD transition	30
#2967 C-reactive protein/serum chloride ratio: a novel marker of all-cause mortality in prevalent chronic haemodialysis patients	29
#1683 Gut permeability, circulating bacterial fragments, and left ventricular strain in peritoneal dialysis	29
#2745 New strategies for capturing undiagnosed chronic kidney disease in patients at risk	29
#1157 Body mass and fluid balance in dialysis: global profiles in Apollo Dial DB	29
#801 Impact of delayed graft function on cardiovascular events in kidney transplant recipients	29
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions	28
#598 Successful application of allo-hemodialysis in a porcine model of embolization-induced acute kidney injury	28
#1063 Impact of geriatric nutritional risk index on renal function in elderly chronic kidney disease patients treated with SGLT2 inhibitors	28
#672 Intradialytic hypotension and adverse symptoms are not related	28
#1281 Torque teno virus load in kidney transplantation: association with donor and recipient characteristics and clinical follow-up data	28
#291 Prevalence and patterns of intradialytic arterial oxygen saturation instability: observations in a large U.S. hemodialysis cohort	27
#2649 Investigation of the Rac1-SGK1 pathway and therapeutic effects of finerenone and Rac1 inhibition in a Fabry disease podocyte model	27
#2398 Exogenous a-Klotho supplementation significantly prolongs survival in a mouse model of alport syndrome, with comparable outcomes to RASi	27
#2590 Evolutionary origins of polycystic kidney disease genes: insights from emerging phylogenomic methodologies	27
#2706 Genetically determined reduction of renal carbonic anhydrase 12 is associated with decreased kidney function and increased serum urate	27
#2588 Renal trajectories in the french RaDiCo Alport syndrome cohort	26
#2889 Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart	26
#3257 Urinary metabolomics in nephrotic syndrome: the experience of “Fondazione Policlinico Universitario A. Gemelli”	26
#1881 Evaluating the clinical and economic impact of SGLT-2 inhibitors for CKD management in the UK: insights from the IMPACT CKD microsimulation model	26
#949 Vitamin K dependent proteins and bone quality in the first year after kidney transplantation	26
#623 SGLT2 inhibitors in adult patients with Alport syndrome: a single center Italian experience	25
#1922 Association of parathyroid hormone and alkaline phosphatase with fracture risk in patients with chronic kidney disease not on dialysis	25
#960 A single-centre service evaluation of patient-centred twice-weekly dialysis delivery	25
#1796 The impact of metabolic syndrome components on renal function in patients with heart failure	25
#3063 Real-world utility of the International IgA Nephropathy Prediction Tool in a tertiary referral centre of nephrology	25
#3134 Implementation of an iohexol-based GFR-measurement in clinical routine	25
#3385 The short and long-term accuracy of urinary C-C motif Chemokine-14 in an ICU population	25
#2638 Recombinant zoster vaccine (RZV) confers persistent immune responses with no safety concerns 4 to 8 years after vaccination of adults with renal transplant	25
#2271 SGLT2 inhibition triggers aestivation-like metabolic switches for water conservation in patients with heart failure—results from DAPA-Shuttle1, a randomized, placebo-controlled trial	24
#3716 Change in mGFR following bariatric surgery: A case-crossover study	24
#1727 Kidney function associated with mortality in hantavirus infection: a cohort study in BRAZIL	24
#3777 Roles of antiHLA antibodies in the onset of MACE in a population of patients on dialysis and on the waiting list for kidney transplant. A retrospective single-center study	24
#2731 Legacy effect of pretransplant immunosuppression in kidney transplant recipients with crescentic glomerulonephritis	24
#2266 Integrating palliative care into nephrology: a single-center “action-research” process	24
#147 Evidence of impaired myocardial perfusion reserve in asymptomatic non-diabetic patients with advanced CKD	24
#2190 The protective effects of a ketogenic diet in experimental glomerulonephritis are independent of the Hca2 receptor	23
#2661 Interplay between polymorphism in the EDNRA gene and endothelin-1 concentration in the blood of patients with chronic kidney disease	23
#1100 “Unraveling the genetic complexity of autosomal dominant polycystic kidney disease: insights from gene conversion events”	23
#3842 Significant association between B lymphocytes and their subpopulations with peripheral T follicular cells is evident in patients with systemic lupus erythematosus (SLE) at remission	23
#3389 Ultrasound evaluation of fluid overload in hemodialysis patients: comparison between VExUS score and lung ultrasound in a cross-sectional study	23
#3075 Comparison of β-blocker with other anti-hypertensive drugs in patients with chronic kidney disease in Korea: a national health insurance data	23
#1644 Evaluation of clinical consequences in diverse forms of fistula elevation procedure	23
#450 Comparison of Thymoglobulin® vs Grafalon® as induction treatment in kidney transplantation with maastricht type III donor	23
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population	22
#3313 A novel identification of anti-hypertensive drug spironolactone as an inhibitor of paraoxonase 2 lactonase and anti-ROS activities	22
#1519 Granulomatous interstitial nephritis in a patient with metastatic melanoma on target therapy with dabrafenib and trametinib: a case report	22
#2491 Exploring the association between non-alcoholic fatty liver disease and chronic kidney disease: insights from NHANES 1999–2016	22
#1793 Renal protective effect of SGLT2 inhibitors in patients with Fabry disease	21
#3838 Hungry bone syndrome (HBS) as an outcome of parathyroidectomy as a treatment of hyperparathyroidism in a third level hospital in a medium-income country	21
#1715 Online prediction of dialysis adequacy failure in hemodialysis	21
#1795 Next-generation sequencing in chronic kidney disease of unknown etiology: a step toward precision medicine	21
#1085 Acute kidney injury in Iraqi cancer patients treated with immune checkpoint inhibitors. (project ICI-AKI Iraq) interim analysis	21
#3692 Granulomatous interstitial nephritis and immunodeficiency—a link to remember	21
#3480 Dehydration and hypertension differently prime intrinsic and pre-renal AKI	21
#3387 Hepatitis, acute kidney injury and myositis due to atorvastatin	21
#2782 Clinician usage and perception of an AI-based model predicting peritoneal dialysis dropouts	21
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis	20
#1048 Why are felids at such a high risk of chronic kidney disease?	20

#3368 The implementation of a multi-faceted cardio-renal service on heart failure and renal outcomes: a retrospective cohort study	20
FHL2 in arterial medial calcification in chronic kidney disease	20
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)	20
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury	20
Transition of care of adolescent kidney transplant recipients—a call to action	20
#3225 Integrating telemedicine into peritoneal dialysis: a holistic model for palliative care in advanced CKD	20
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity	19
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial	19
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies	19
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future	19
Towards carbon footprint measurement of the ERA Congress: five key strategies for greener events	19
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?	19
#2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE	19
#1685 Multimodal spatial profiling of microvascular inflammation in kidney allografts	18
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study	18
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective	18
Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria	18
#1936 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)	18
On the fragility of outcome measures of two individual patient data analyses from randomized controlled trials on online haemodiafiltration	18
Are patients with primary glomerular disease at increased risk of malignancy?	18
#560 The representation of multimorbidity and frailty in the development and validation of kidney failure risk prediction models – a systematic review	18
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI	18
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients	18
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines	18
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN	18
Modeling podocytopathies with kidney organoids	18
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients	17
Hippocampal subfield morphology in regular hemodialysis patients	17
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis	17
Cognitive deficits associate with cerebral hypoxia during hemodialysis	17
Correction to: Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin	17
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy	17
Time trends in preemptive kidney transplantation in Europe: an ERA registry study	17
Trends in nephrology: from treating kidney disease to maintaining kidney health	17
Clinical applications of artificial intelligence in autosomal dominant polycystic kidney disease	17
#3268 Cognitive decline in hemodialysis patients : a prospective cross-sectional study analysing sociodemographic and clinical determinants	17
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease	17
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport	16
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease	16
#2067 Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning techniques	16
Long-term outcome of kidney function in patients with ANCA-associated vasculitis	16
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications	16
Global, regional and national burden of CKD in children and adolescents	16
Pediatric kidney care experience after the 2023 Türkiye earthquake	16
Uromodulin biology	16
Immunoengineering for autoimmune-kidney disease	16
#4735 USEFULNESS OF CYSTATIN C IN MEASURING RENAL FUNCTION AND PREDICTING METHOTREXATE ASSOCIATED TOXICITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS	16
#4344 CHANGES IN ENERGY METABOLISM IN THE KIDNEY WITH TUBULOINTERSTITIAL FIBROSIS: AN EX VIVO WHOLE TISSUE 2D-COSY APPROACH	15
#5734 RENAL AUTOLOGOUS CELL THERAPY (REACT™) FOR DIABETIC CHRONIC KIDNEY DISEASE: PHASE II TRIAL WITH BILATERAL CORTEX INJECTIONS AND RE-DOSING TRIGGERS	15
#228 APOL1 variants and chronic kidney disease in Morocco: case control study	15
#3520 THE RELATIONSHIPS OF BONE TURNOVER MARKERS AND CEREBRAL WHITE MATTER ALTERATIONS IN PATIENTS UNDERGOING HEMODIALYSIS	15
#5093 DIALYSIS PATIENTS AND BNT162B2MRNA VACCINE TYPE ARE RISK FACTORS FOR IMMUNITY FADING 9 MONTHS AFTER SARS-COV-2MRNA VACCINATION (DIA-VACC STUDY)	15
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN	15
#5341 EFFECTS OF URIC ACID-LOWERING THERAPY ON RENAL OUTCOMES IN CKD PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS	15
#832 Sickle cell trait and APOL1 high risk genotype increase the risk of ESKD similar to diabetes in British Africans	15
#3459 GLUCOSE-LOWERING THERAPIES IN END STAGE RENAL DISEASE: HOW CAN WE PREDICT THE RISK OF HYPOGLYCAEMIA?	15
#6691 COMPREHENSIVE TWO-DAY IN-HOSPITAL ASSESSMENT MODE IS ASSOCIATED WITH THREE-YEAR AND FIVE-YEAR MORTALITY IN PERITONEAL DIALYSIS PATIENTS	15
#6898 CATHETER RELATED BLOODSTREAM INFECTION IN NON-TUNNELED HEMODIALYSIS CATHETERS IN A RESOURCE-LIMITED HOSPITAL IN MERIDA, YUCATAN, MEXICO	15
#3865 TELEMEDICINE IN NEPHROLOGY: A CROSS-SECTIONAL STUDY	15
#5852 EFFECT OF DIET ON THE COLLECTOR DUCT BEHAVIOUR: RELEVANCE IN PRECLINICAL DRUG DEVELOPMENT	14
#6738 ALCOHOL LOCK IN CRBSI: A PANACEA	14
#921 Interferon regulatory factor 4 (IRF4)-specific deletion on dendritic cells protects against kidney inflammation and injury in IRI-induced AKI/AKD	14
#3435 UNPLANNED INITIATION OF HEMODIALYSIS IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE: RISK FACTORS FOR SHORT TERM MORTALITY	14
#1286 Utility of cinacalcet treatment in kidney transplant recipients with persistent hyperparathyroidism	14
#3163 SARS-COV-2 OMICRON INFECTIONS AMONG VACCINATED MAINTENANCE HEMODIALYSIS PATIENTS: OUTCOMES AND COMPARISON TO DELTA VARIANT	14
#2999 APABETALONE REDUCES CARDIAC EVENTS IN CKD PATIENTS BY DOWNREGULATING FIBROTIC AND INFLAMMATORY PROCESSES	14
#3989 INTERACTIVE-HD 2.0 PROJECT – PRELIMINARY RESULTS OF LUGANO DATASET	14
#4152 CROSS-OMICS PROFILING OF PROTEOME, METABOLOME, AND TRANSCRIPTOME REVEALS MOLECULE AND CLEARANCE DYNAMICS AND ORIGIN IN PERITONEAL DIALYSIS	14
#4100 ACUTE KIDNEY INJURY, GLOMERULONEPHRITIS AND TUBULOINTERSTITIAL NEPHRITIS FOLLOWING VACCINATION: VIGIBASE ANALYSIS	14
#2454 Meeting guideline goals at hemodialysis patients impact their survival?	14
#5703 COVID-19, RENAL DAMAGE AND ITS EVOLUTION IN HOSPITALISED PATIENTS IN THE FIRST WAVE OF THE PANDEMIC: EXPERIENCE OF ONE CENTRE	14
#3122 30-DAY COMPLICATIONS IN PERITONEAL DIALYSIS CATHETERS INSERTED PERCUTANEOUSLY VERSUS SURGICALLY IN A SECOND LEVEL HOSPITAL IN MERIDA, YUCATAN, MEXICO	14
#3956 PRIORITY OUTCOMES FOR EDUCATION AND SELF-MANAGEMENT IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A PATIENT AND PROFESSIONAL DELPHI SURVEY	14
#1082 Early-stage chronic kidney disease as a risk factor for suicide: a nationwide observational cohort study	14
#443 LEVIL evaluates the impact of HDx on HR-QoL and symptoms, including durability-of-effect and variability	14
#58 SGLT2 inhibitor kidney outcome trials: under-representation of the majority of people with chronic kidney disease in real-world clinical practice	14
#3434 A FREE OPEN-SOURCE FRAMEWORK TO INFER PATIENT-LEVEL EGFR SLOPES FOR ASSOCIATION WITH MOLECULAR DATA	14
#5686 CANCER STATUS AND MORTALITY IN ELDERLY INCIDENT HEMODIALYSIS PATIENTS	13
#1207 Post transplant diabetes mellitus in kidney transplanted patients: factors related and impact on long-term outcome	13
#3447 ENVIRONMENTAL MELAMINE EXPOSURE AND ADVERSE KIDNEY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS	13
#4769 EFFECT OF EXTREMELY LONG DIALYSIS VINTAGE ON RENAL ALLOGRAFT SURVIVAL: A SINGLE-CENTER EXPERIENCE	13
#6153 SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS VERSUS DIPEPTIDYL PEPTIDASE 4 INHIBITORS AS STABILIZERS OF HIF PATHWAY IN DIABETIC NEPHROPATHY RATS	13
#2674 ASSOCIATION BETWEEN SARCOPENIA, BODY COMPOSITION AND FRAILTY IN PERITONEAL DIALYSIS PATIENTS: A MULTI-CENTRIC STUDY	13
#5128 PREDICTIVE FACTORS OF RENAL RECOVERY AND END-STAGE KIDNEY DISEASE IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS WITH GLOMERULONEPHRITIS	13
#2293 Cardiac autonomic neuropathy: an independent risk factor for renal decline in diabetic kidney disease	13
#5932 BALKAN ENDEMIC NEPHROPATHY AND MALIGNANT TUMOR OF THE UPPER TRACT UROTELIUM: AFTER 45 YEARS	13
#3930 EFFECT OF TWO PHOSPHATE BINDERS ON VITAMIN D LEVELS IN HEMODIALYSIS PATIENTS	13
#2283 Vitamin D metabolism in end stage kidney failure: people receiving haemodialysis can still synthesise 1,25-dihydroxyvitamin D	13
#4534 FINERENONE ADDED TO RAS/SGLT2 BLOCKADE FOR NON-DIABETIC CHRONIC KIDNEY DISEASE: RESULTS OF A PRECLINICAL DOUBLE-BLINDED RANDOMIZED CONTROLLED TRIAL	13
#5213 RELATIONSHIP BETWEEN CYTOKINE RELEASE SYNDROME AND ACUTE KIDNEY INJURY AFTER CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN HEMATOLOGIC NEOPLASMS	13
#4204 MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BIOMARKERS OUTPERFORM LAB BIOMARKERS FOR PREDICTING PROGRESSION OF DIABETIC KIDNEY DISEASE	13
#5837 MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF THE PERITONEAL MESOTHELIAL AND ENDOTHELIAL CELL BARRIER	13
#271 The nexus between TMA/TTP, MIS-C, and SLE	13
#4772 DOUBLE FILTRATION PLASMAPHERESIS DURING HETEROLOGOUS FERTILIZATION PREGNANCY FOR THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	13
#3719 INCIDENCE, OUTCOMES AND RISK FACTORS OF ACUTE KIDNEY INJURY IN PATIENTS THAT UNDERWENT TRANSCATHETER AORTIC VALVE REPLACEMENT	13